WuXi AppTec Co., the Shanghai-listed contract medical researcher, has raised $1.01 billion after pricing its Hong Kong first-time share sale above the midpoint of a marketed range, according to people with knowledge of the matter.
Continue reading this story with a subscription to DealStreetAsia.
Already a subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com.
